. Author manuscript; available in PMC: 2014 Sep 19.

Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. doi: 10.1002/14651858.CD006625.pub2

Analysis 2.26. Comparison 2 QUETIAPINE versus OLANZAPINE, Outcome 26 Adverse effects: 7a. Metabolic - cholesterol - significant cholesterol increase.

Review: Quetiapine versus other atypical antipsychotics for schizophrenia

Comparison: 2 QUETIAPINE versus OLANZAPINE

Outcome: 26 Adverse effects: 7a. Metabolic - cholesterol - significant cholesterol increase